Opendata, web and dolomites

BioMensio SIGNED

BioMensio mobile biosensing platform: the first truly palm-sized and accurate digital multi-drug test

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BioMensio project word cloud

Explore the words cloud of the BioMensio project. It provides you a very rough idea of what is the project "BioMensio" about.

fatalities    prevent    variety    detect    accuracy    saliva    proof    mishandling    patient    market    first    patented    alcohol    worldwide    injuries    drivers    bulkiness    efficient    caused    uncertain    legalisation    mass    influence    drugs    fatal    drive    suited    found    accelerator    employers    norms    heavy    designed    preventative    machinery    deploying    palm    ready    fuelled    narcotics    government    workplace    illicit    reduce    helps    mechanism    driving    levels    sized    intoxication    bio    surpassed    exceeds    tools    rapid    million    company    hampered    performance    off    minutes    people    administrate    virtually    accurate    backed    provides    globally    war    stage    drugged    centre    traffic    instrumentation    finland    siemens    platform    stringent    accidents    sensing    paramedics    understand    biomensio    billion    deployment    vtt    coming    device    solutions    spin    police    simultaneously    drug    deaths    person    inability   

Project "BioMensio" data sheet

The following table provides information about the project.

Coordinator
BIOMENSIO OY 

Organization address
address: HERMIANKATU 6-8 H
city: TAMPERE
postcode: 33720
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Finland [FI]
 Total cost 3˙560˙030 €
 EC max contribution 2˙492˙021 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-03-01   to  2021-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIOMENSIO OY FI (TAMPERE) coordinator 2˙492˙021.00

Map

 Project objective

In the EU, well over 8 million people have been found to drive under the influence of illicit drugs. In the US, fatal traffic accidents caused by drugged driving has already surpassed alcohol-induced traffic deaths. Drug intoxication testing is an efficient mechanism that helps to avoid drug related fatalities, such as traffic accidents or heavy machinery mishandling. However, the current testing solutions are not suited for wide scale deployment and thus cannot make a meaningful impact in the war against drugs. They are hampered by the bulkiness and high cost of instrumentation, uncertain levels of accuracy, and inability to detect the growing variety of drugs.

BioMensio multi-drug testing platform is the first palm-sized and highly accurate device to detect drug intoxication from saliva, designed specifically for the police to detect drugged drivers, paramedics to better understand patient condition, and employers to prevent workplace injuries. Our patented bio-sensing technology enables to simultaneously measure a person’s intoxication from virtually any widely used narcotics, in an easy-to-administrate test that provides results in just 1-2 minutes. This by far exceeds the performance of any other current or up-and-coming technology.

BioMensio is a spin-off company from Siemens Technology Accelerator and VTT Technical Research Centre of Finland, and has been backed with €3.5 million early stage funding. We are now beyond the proof-of-concept phase and are ready to scale our technology. We target the globally growing €1 billion saliva-based rapid drug testing market, which is fuelled by increasingly stringent government norms and workplace drug testing legalisation worldwide. As the key to reduce drug related fatalities and injuries is widely deploying and applying preventative tools, the main goal of our project is bring our patented bio-sensing platform to the mass market.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BIOMENSIO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BIOMENSIO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DNA DS (2019)

DNA Data storage

Read More  

ERGOVIAkinematix (2018)

New wearable measurement devices for Industry 4.0 based on gaming motion-capture system

Read More  

Magnesys (2019)

Efficient filtering of metallic impurities in food processing

Read More